首页> 外文期刊>Journal of Huazhong University of Science and Technology >Difference in Expression of Bcl-2 and Bcl-xl Genes in Cisplatin- sensitive and Cisplatin-resistant Human in Ovarian Cancer Cell Lines
【24h】

Difference in Expression of Bcl-2 and Bcl-xl Genes in Cisplatin- sensitive and Cisplatin-resistant Human in Ovarian Cancer Cell Lines

机译:Bcl-2和Bcl-xl基因在卵巢癌细胞系中对顺铂敏感和顺铂耐药的人中表达的差异

获取原文
获取原文并翻译 | 示例
           

摘要

To investigate the expression of Bcl-2 and Bcl-xl gene in sensitive (A2780) and drug-resistance (AD6) human ovarian cancer cell lines and explore the molecular mechanism of multidrug resistance, A2780 and AD6 were detected by using DNA gel electrophoresis, flow cytometry and RT-PCR. Our results showed that (1)"DNA ladder " was observed in A2780 and AD6 after cispla-tin treatment; (2) after 3. 0, 6. 0, 9. 9 μg/ml of cisplatin treatment, a significant difference was noted in the rate of apoptosis between in A2780 and AD6 (P<0. 05) ; (3) Bcl-2 and Bcl-xl genes were overexpressed in AD6. After cisplatin treatment, the expression of Bcl-2 and Bcl-xl genes was down-regulated in A2780 and AD6. It is concluded that cisplatin could induce the apoptosis of ovarian cancer cells, and the over-expression of Bcl-2 and Bcl-xl genes may contribute to apoptotic inhibition and the development of multidrug-resistance of human ovarian cancer.
机译:为了研究Bcl-2和Bcl-xl基因在敏感(A2780)和耐药(AD6)人卵巢癌细胞系中的表达,并探讨多药耐药的分子机制,通过DNA凝胶电泳检测A2780和AD6,流式细胞仪和RT-PCR。我们的结果表明:(1)顺铂处理后在A2780和AD6中观察到“ DNA阶梯”; (2)在3. 0、6。0、9。9μg/ ml顺铂处理后,A2780和AD6的凋亡率之间存在显着差异(P <0。05); (3)Bcl-2和Bcl-xl基因在AD6中过表达。顺铂处理后,Bcl-2和Bcl-xl基因的表达在A2780和AD6中被下调。结论:顺铂可诱导卵巢癌细胞凋亡,Bcl-2和Bcl-xl基因的过度表达可能促进其凋亡抑制作用并发展为人多药耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号